SCHEMBL7597272

SCHEMBL7597272

CNc1ccc(-c2ccc(C(=O)NC3C4CCN(CC4)C3C)[nH]2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.39
PTPN11 Q06124 1/20 0.39
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
USP2 O75604 1/20 0.34
HSD17B10 Q99714 1/20 0.34
WNT3A P56704 1/20 0.32
CHRNB2 P17787 3/20 0.32
CHRNA7 P36544 3/20 0.32
CHRNA4 P43681 3/20 0.32
SLC18A3 Q16572 4/20 0.32
ALDH1A1 P00352 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CYP1A2 P05177 2/20 0.31
CYP2C19 P33261 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7117096 1.00 PTPN1 (0.39) PTPN1PTPN11KDM4EHPGDUSP2
SCHEMBL7127049 0.90 KDM4E (0.46) PTPN1PTPN11KDM4EHPGDUSP2
SCHEMBL7118038 0.90 PTPN1 (0.38) PTPN1PTPN11KDM4EHPGDUSP2
SCHEMBL7117729 0.89 PTPN1 (0.42) PTPN1PTPN11KDM4ESLC18A3ALDH1A1
SCHEMBL7115882 0.89 CHRNA7 (0.38) PTPN1PTPN11KDM4EHPGDUSP2
SCHEMBL7117126 0.89 PTPN1 (0.49) PTPN1PTPN11KDM4EHPGDUSP2
SCHEMBL7123565 0.89 CHRNA7 (0.38) PTPN1PTPN11KDM4EHPGDUSP2
SCHEMBL7595144 0.89 PTPN1 (0.49) PTPN1PTPN11KDM4EHPGDUSP2
SCHEMBL7129276 0.89 PTPN1 (0.38) PTPN1PTPN11KDM4EHPGDUSP2
SCHEMBL7130837 0.89 PTPN1 (0.44) PTPN1KDM4EHPGDUSP2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002015662-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed